Building Australia’s World‑Class Healthcare Future
Securing Health and Vitality for Every Aussie
We love the Australian way of life. The vitality. The mateship. And the belief that everyone deserves a fair crack.
These qualities are very Australian. And they’re very us.
.jpg/:/cr=t:0%25,l:0%25,w:100%25,h:98.46%25/rs=w:1209,h:605,cg:true)
Hope for a World-class Health System
To love life, grasp opportunities and enjoy friends and family requires good health and, when health fades, it requires help getting better, fitter and healthier.
Australia’s healthcare system is rightly recognised as being among the world’s finest. But even the finest healthcare system can fail. And when it does, people suffer.
That’s why Hilaxon exists.
.jpg/:/cr=t:0%25,l:4.2%25,w:90.39%25,h:100%25/rs=w:1209,h:605,cg:true)
Support for Healthcare Professionals
We recognise, celebrate and advocate Australia’s vitality.
We work each and every day to help keep Australians strong and active by collaborating with a network of partners to ensure Australians have access to the most medically appropriate drugs and devices, supporting both local and international pharmaceutical companies in navigating the Australian market.
We give support to healthcare professionals. And hope to every Australian battling ill health or a physical or mental condition. This is our mission. And why we say: where there’s Hilaxon, there’s hope.
WHY US
Excellence for Life
At the heart of Hilaxon is a commitment to excellence, collaboration, and innovation.
We engage with Australia’s leading healthcare professionals, patient groups, and industry experts to bring innovative therapies onto the market.
Our approach is deeply rooted in understanding local and international medical needs, ensuring a tailored strategy for each product we introduce to the Australian market.
A Strategic and Unique Network
We’ve built a strong and trusted pharmaceutical network that connects international companies with reliable partners across import, distribution, and storage.
With our end-to-end approach, we help ensure that every product moves smoothly, from regulatory approval all the way to the hands of healthcare professionals and the patients who need them.
This thoughtful infrastructure isn’t just about efficiency—it’s about getting important therapies to market faster, without ever compromising on quality or compliance.
Global Partners, Local insights
We are proud to partner with some of the world’s leading pharmaceutical, medical device, and biotech companies to bring life-changing solutions to patients in Australia. Our deep understanding of international regulatory frameworks spanning the TGA, FDA, EMA, MHRA, and Health Canada helps streamline approvals in Australia.
But we do more than just navigate the rules, we help our partners adapt to evolving regulations and emerging trends. It’s how we support long-term, sustainable growth in an industry that never stands still, whilst keeping patients at the heart of what we do.
Commitment to Innovation
At Hilaxon, we embrace innovation with heart. As a forward-thinking consultancy, we combine the latest in regulatory technology, AI-powered medical writing, and compliance automation with the insight and care of real human expertise. It’s this balance that allows us to deliver smart, efficient solutions, without ever losing the personal touch.
We keep a close eye on industry shifts, from regulatory updates to emerging technologies and evolving patient needs, so our clients can stay confident and ahead of the curve. Whether you’re stepping into the Australian market for the first time or growing your existing presence, we’re here as your trusted partner, helping you navigate the complexities and uncover new opportunities with clarity and care.
Our Core Values
A Values Driven Approach
At the heart of everything we do are the values that guide us, not just in how we work, but in how we care. These principles shape every partnership, every strategy, and every step we take towards better health outcomes.
Rewarding Relationships
Built on trust, transparency, and expertise – we believe in creating partnerships that last and truly matter.
Unique Solutions
Unique Solutions
No two journeys are the same. We craft thoughtful, tailored strategies to overcome regulatory and commercial barriers, allowing clients to achieve sustainable growth.
Smart Care
Unique Solutions
We bring together intelligence and empathy to serve both our clients and the patients they impact.
From our humble beginignts to today
2026: Integration and Innovation
We completed full operational integration with Hilaxon in 2025, consolidating systems, unifying customer support, and combining service offerings. RegulatoryEdge clients now benefit from Hilaxon's integrated services, maintaining the same local expertise and commitment to compliant, timely solutions.
We also continue to advance our capabilities in AI innovation, staying at the forefront of its expanding applications within the pharmaceutical industry.
At the 2026 ARCS conference, we officially launched the Hilaxon brand, positioning ourselves as a strategic partner ready to address your operational challenges and drive sustainable growth. If you're ready to partner with a team delivering measurable results, let's connect.
2025: Exhibiting at ARCS Annual Conference
Thanks to ARCS Australia and everyone who visited our booth. It was great reconnecting with familiar faces and meeting new ones across our industry. The sessions sparked valuable conversations on topics from regulatory strategy to patient safety and highlighted the importance of sharing experiences, not just data.
At Hilaxon we’re seeing increased demand for regulatory clarity, especially in early stage planning and TGA readiness. Hilaxon brings practical Australian regulatory expertise to help sponsors move from strategy to execution. If you have questions about bringing a therapeutic product to market in Australia, reach out, we’re happy to help.
2024: A New Chapter for RegulatoryEdge and HILAXON
We'd embarked on an exciting journey of growth and transformation. RegulatoryEdge began evolving into Hilaxon. This transition embraced a fresh identity that aligned with our vision for the future, reflecting our expanded services and capabilities.
While the name and branding took on a new look, the essence and personal touch of our company remained. At Hilaxon, our clients continued to expect the same dedicated, individualised attention and service they'd come to know and appreciate.
Thank you for being part of our journey.
2023: Harnessing AI Innovation in Life Sciences
We’ve been building on decades of tech expertise—starting with programming in BASIC and C++ under founder Enisa—and have continued learning to lead AI applications in Life Sciences, especially Regulatory Affairs and Drug Safety.
In 2023 our team completed the intensive 1:1 course “AI Is My CoPilot” with Laurel Papworth, gaining practical skills with generative AI and large language models. Since then we’ve continued learning and applied those techniques to create tailored solutions for regulatory compliance, pharmacovigilance, medical affairs, and business development.
Partner with Hilaxon to translate AI innovation into practical Life Sciences outcomes: streamline regulatory workflows, boost drug-safety insights, and accelerate growth. Contact us to explore AI-driven projects that improve efficiency and decision-making.
Meet our Founder
Enisa Savic Hjelmaas is commercially orientated pharmacologist with extensive experience in Scientific Affairs working across a number of various functions, product portfolios and therapeutic areas within the pharmaceutical industry. She is multilingual with international experience.
Key area of expertise include regulatory affairs consulting in area of regulatory development, submissions and commercialisation of products, critical review and analysis of manufacturing, toxicology and clinical data, and negotiation of win-win outcomes with regulatory authorities. Her expertise also extends to medical affairs and pharmacovigilance as well as skills such as project management, and leadership of cross functional initiatives with global scope, ultimately achieving greater business efficiencies and maximising commercial opportunities.
Enisa's LinkedIn profile is a testament to her industry reputation and expertise, featuring numerous endorsements from colleagues and clients who attest to her skills, knowledge, and professionalism. These endorsements highlight her ability to deliver exceptional results, build strong relationships, and navigate complex regulatory challenges effectively.
On personal level Enisa is creative, strategic, efficient, and results-oriented problem solver with solid sense of business. She possesses persuasive negotiation skills and enjoys challenging environments, thriving as key member of achievement-oriented team.
2017: RegulatoryEdge Journey Begins
Enisa Savic Hjelmaas founded RegulatoryEdge Consultancy in 2017 to meet demand for commercially oriented regulatory affairs consulting services. The firm built a reputation for integrity, professionalism and deep local expertise by attracting and retaining top Australian talent and refusing to outsource work offshore, ensuring confidential, attentive delivery on time and within budget.
RegulatoryEdge became known for its specialist knowledge of the Australian regulatory landscape, a client‑centric approach, and a comprehensive regulatory affairs service offering that supported growth and compliance for Australian and international life‑science companies. Its clients included established firms and start-ups across ethical medicines (small molecules, biologicals and gene therapies), over‑the‑counter medicines, medical devices and cosmetics.